PSTX's logo.
Ticker Symbol: PSTX

Poseida Therapeutics Inc

$7.19 - 07-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001661460

Company Profile

Poseida Therapeutics is a clinical-stage biopharmaceutical company dedicated to utilizing our proprietary genetic engineering platform technologies to create next generation cell and gene therapeutics with the capacity to cure. Poseida has discovered and are developing a broad portfolio of product candidates in a variety of indications based on our core proprietary platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVER™ site-specific gene editing system and nanoparticle- and AAV-based gene delivery technologies. Its core platform technologies have utility, either alone or in combination, across many cell and gene therapeutic modalities and enable us to engineer its wholly-owned portfolio of product candidates that are designed to overcome the primary limitations of current generation cell and gene therapeutics.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 9390 Towne Centre Drive
Website: poseida.com
CEO: Eric Ostertag
Tags:
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

Pricing

Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $2.34
Change: $0.18 ( 8.33%)
Days Range: $2.03 - $2.35
Beta: 1.35
52wk. High: $8.82
52wk. Low: $1.54
Ytd. Change -50.91%
50 Day Moving Average: $2.21
200 Day Moving Average: $2.31
Shares Outstanding: 86916199

Valuation

Market Cap: 20.3B
PE Ratio: -6.72
EPS (TTM): -0.3482

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A